Constantine Davides
Stock Analyst at JMP Securities
(0.87)
# 2,813
Out of 4,412 analysts
60
Total ratings
29.31%
Success rate
-30.42%
Average return
Main Sectors:
26 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Reiterates: Market Outperform | $15 | $10.12 | +48.22% | 2 | Apr 16, 2024 | |
| HQY HealthEquity | Initiates: Market Outperform | $101 | $80.26 | +25.84% | 1 | Apr 4, 2024 | |
| CERT Certara | Initiates: Market Perform | n/a | $16.57 | - | 1 | Apr 4, 2024 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $87 → $75 | $57.12 | +31.30% | 3 | Feb 26, 2024 | |
| EVH Evolent Health | Maintains: Market Outperform | $37 → $38 | $27.65 | +37.43% | 2 | Feb 23, 2024 | |
| PRVA Privia Health Group | Initiates: Market Outperform | $27 | $18.26 | +47.86% | 1 | Dec 6, 2023 | |
| HSTM HealthStream | Initiates: Market Perform | n/a | $25.61 | - | 1 | Dec 6, 2023 | |
| CCRN Cross Country Healthcare | Initiates: Market Perform | n/a | $17.14 | - | 1 | Dec 6, 2023 | |
| AGL agilon health | Initiates: Market Outperform | $18 | $5.00 | +260.00% | 1 | Dec 6, 2023 | |
| NMRD Nemaura Medical | Maintains: Buy | $6 → $4 | $0.05 | +7,280.07% | 4 | Jul 17, 2023 | |
| NNVC NanoViricides | Assumes: Buy | $5.25 | $1.10 | +377.27% | 3 | Jun 1, 2023 | |
| MEDS TRxADE HEALTH | Maintains: Buy | $26 → $19 | $6.31 | +197.15% | 2 | May 16, 2023 | |
| LGVN Longeveron | Reiterates: Buy | $125 | $1.75 | +7,042.86% | 5 | May 16, 2023 | |
| ELMD Electromed | Reiterates: Buy | $15 | $15.77 | -4.88% | 3 | May 11, 2023 | |
| INVA Innoviva | Reiterates: Buy | $23 | $15.26 | +47.44% | 4 | May 10, 2023 | |
| CCLD CareCloud | Reiterates: Buy | $8.5 | $1.08 | +686.96% | 2 | May 5, 2023 | |
| HOTH Hoth Therapeutics | Reiterates: Buy | $14 | $1.16 | +1,106.90% | 4 | Apr 27, 2023 | |
| HCWB HCW Biologics | Reiterates: Buy | $9 | $1.40 | +542.90% | 4 | Apr 19, 2023 | |
| BBLG Bone Biologics | Reiterates: Buy | $540 | $1.53 | +35,194.12% | 3 | Apr 13, 2023 | |
| KTTA Pasithea Therapeutics | Maintains: Buy | $46 → $40 | $6.85 | +483.94% | 2 | Apr 3, 2023 | |
| VNRX VolitionRx | Reiterates: Buy | $6 | $0.91 | +556.67% | 2 | Mar 16, 2023 | |
| ACST Acasti Pharma | Reiterates: Buy | $15 | $2.90 | +417.24% | 2 | Feb 15, 2023 | |
| BIVI BioVie | Maintains: Buy | $14 → $8 | $0.48 | +1,550.17% | 2 | Sep 28, 2022 | |
| HCTI Healthcare Triangle | Maintains: Buy | $40 → $20 | $1.27 | +1,474.80% | 2 | Sep 28, 2022 | |
| ISPC iSpecimen | Maintains: Buy | $5.5 → $4.25 | $0.27 | +1,497.74% | 2 | Sep 23, 2022 | |
| TCBP TC Biopharm (Holdings) | Initiates: Buy | $50,000 | $1.53 | +3,267,873.86% | 1 | Mar 28, 2022 |
OptimizeRx
Apr 16, 2024
Reiterates: Market Outperform
Price Target: $15
Current: $10.12
Upside: +48.22%
HealthEquity
Apr 4, 2024
Initiates: Market Outperform
Price Target: $101
Current: $80.26
Upside: +25.84%
Certara
Apr 4, 2024
Initiates: Market Perform
Price Target: n/a
Current: $16.57
Upside: -
AMN Healthcare Services
Feb 26, 2024
Maintains: Market Outperform
Price Target: $87 → $75
Current: $57.12
Upside: +31.30%
Evolent Health
Feb 23, 2024
Maintains: Market Outperform
Price Target: $37 → $38
Current: $27.65
Upside: +37.43%
Privia Health Group
Dec 6, 2023
Initiates: Market Outperform
Price Target: $27
Current: $18.26
Upside: +47.86%
HealthStream
Dec 6, 2023
Initiates: Market Perform
Price Target: n/a
Current: $25.61
Upside: -
Cross Country Healthcare
Dec 6, 2023
Initiates: Market Perform
Price Target: n/a
Current: $17.14
Upside: -
agilon health
Dec 6, 2023
Initiates: Market Outperform
Price Target: $18
Current: $5.00
Upside: +260.00%
Nemaura Medical
Jul 17, 2023
Maintains: Buy
Price Target: $6 → $4
Current: $0.05
Upside: +7,280.07%
NanoViricides
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.10
Upside: +377.27%
TRxADE HEALTH
May 16, 2023
Maintains: Buy
Price Target: $26 → $19
Current: $6.31
Upside: +197.15%
Longeveron
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.75
Upside: +7,042.86%
Electromed
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $15.77
Upside: -4.88%
Innoviva
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $15.26
Upside: +47.44%
CareCloud
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $1.08
Upside: +686.96%
Hoth Therapeutics
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.16
Upside: +1,106.90%
HCW Biologics
Apr 19, 2023
Reiterates: Buy
Price Target: $9
Current: $1.40
Upside: +542.90%
Bone Biologics
Apr 13, 2023
Reiterates: Buy
Price Target: $540
Current: $1.53
Upside: +35,194.12%
Pasithea Therapeutics
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $6.85
Upside: +483.94%
VolitionRx
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.91
Upside: +556.67%
Acasti Pharma
Feb 15, 2023
Reiterates: Buy
Price Target: $15
Current: $2.90
Upside: +417.24%
BioVie
Sep 28, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $0.48
Upside: +1,550.17%
Healthcare Triangle
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $1.27
Upside: +1,474.80%
iSpecimen
Sep 23, 2022
Maintains: Buy
Price Target: $5.5 → $4.25
Current: $0.27
Upside: +1,497.74%
TC Biopharm (Holdings)
Mar 28, 2022
Initiates: Buy
Price Target: $50,000
Current: $1.53
Upside: +3,267,873.86%